Bio-Techne
TECH
#1989
Rank
NZ$16.68 B
Marketcap
NZ$107.09
Share price
-2.93%
Change (1 day)
-14.38%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

EPS for Bio-Techne (TECH)

EPS in 2025 (TTM): NZ$0.89

According to Bio-Techne's latest financial reports the company's current EPS (TTM) is NZ$0.87. In 2024 the company made an earnings per share (EPS) of NZ$1.74 a decrease over its 2023 EPS that were of NZ$2.47.

EPS history for Bio-Techne from 2014 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$0.89-48.87%
2024NZ$1.74-29.58%
2023NZ$2.47-14.97%
2022NZ$2.9024.16%
2021NZ$2.3417.98%
2020NZ$1.98-10.94%
2019NZ$2.22101.57%
2018NZ$1.10-16.99%
2017NZ$1.3345.02%
2016NZ$0.92-20.97%
2015NZ$1.16-14.97%
2014NZ$1.36

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
NZ$30.11 3,368.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
NZ-$42.21-4,962.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
NZ$9.67 1,014.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Danaher
DHR
NZ$8.47 876.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
NZ$3.24 273.74%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
General Electric
GE
NZ$13.13 1,412.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
NZ-$0.36-142.00%๐Ÿ‡บ๐Ÿ‡ธ USA